Saad F - Search Results

1

Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial.

Armstrong AJ, Lin P, Tombal B, Saad F, Higano CS, Joshua AM, Parli T, Rosbrook B, van Os S, Beer TM. Armstrong AJ, et al. Among authors: saad f. Eur Urol. 2020 Sep;78(3):347-357. doi: 10.1016/j.eururo.2020.04.061. Epub 2020 Jun 9. Eur Urol. 2020. PMID: 32527692 Free article. Clinical Trial.

2

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Chen B; Zoledronic Acid Prostate Cancer Study Group. Saad F, et al. J Natl Cancer Inst. 2002 Oct 2;94(19):1458-68. doi: 10.1093/jnci/94.19.1458. J Natl Cancer Inst. 2002. PMID: 12359855 Clinical Trial.

3

Role of bisphosphonates in prostate cancer.

Saad F, Schulman CC. Saad F, et al. Eur Urol. 2004 Jan;45(1):26-34. doi: 10.1016/j.eururo.2003.10.003. Eur Urol. 2004. PMID: 14667511 Review.

4

Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer.

Reed SD, Radeva JI, Glendenning GA, Saad F, Schulman KA. Reed SD, et al. Among authors: saad f. J Urol. 2004 Apr;171(4):1537-42. doi: 10.1097/01.ju.0000116777.94426.60. J Urol. 2004. PMID: 15017215 Clinical Trial.

5

Bone health in men with prostate cancer: diagnostic and therapeutic considerations.

Saad F, Perrotte P, Bénard F, McCormack M, Karakiewicz PI. Saad F, et al. Can J Urol. 2005 Jun;12 Suppl 2:9-15. Can J Urol. 2005. PMID: 16018826 Review.

6

Natural history and treatment of bone complications in prostate cancer.

Saad F, Clarke N, Colombel M. Saad F, et al. Eur Urol. 2006 Mar;49(3):429-40. doi: 10.1016/j.eururo.2005.12.045. Epub 2006 Jan 6. Eur Urol. 2006. PMID: 16431012 Review.

7

Therapeutic approach to hormone-refractory prostate cancer.

Saad F, Al Dejmah A, Perrotte P, McCormack M, Bénard F, Valiquette L, Karakiewicz PI. Saad F, et al. Can J Urol. 2006 Apr;13 Suppl 2:52-6. Can J Urol. 2006. PMID: 16672130 Review.

8

The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel.

Saad F, Higano CS, Sartor O, Colombel M, Murray R, Mason MD, Tubaro A, Schulman C. Saad F, et al. Clin Genitourin Cancer. 2006 Mar;4(4):257-62. doi: 10.3816/CGC.2006.n.004. Clin Genitourin Cancer. 2006. PMID: 16729908 Review.

9

Sunitinib relieves renal cell carcinoma spinal cord compression.

Trinh QD, Cardinal E, Gallina A, Perrotte P, Saad F, Karakiewicz PI. Trinh QD, et al. Among authors: saad f. Eur Urol. 2007 Jun;51(6):1741-3. doi: 10.1016/j.eururo.2006.10.050. Epub 2006 Nov 3. Eur Urol. 2007. PMID: 17126991

10

Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.

Gallina A, Jeldres C, Chun FK, Shariat SF, Briganti A, Walz J, Roehrborn CG, Saad F, Huland H, Graefen M, Montorsi F, Karakiewicz PI. Gallina A, et al. Among authors: saad f. Eur Urol. 2007 Nov;52(5):1374-80. doi: 10.1016/j.eururo.2006.12.010. Epub 2006 Dec 11. Eur Urol. 2007. PMID: 17174466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,350 results

Search Page